人類CellExp™IL-29,人類重組蛋白 | 貨號6473-50

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |
特點
人類CellExp™IL-29,人類重組蛋白 | 貨號6473-50
Human CellExp™ IL-29, Human Recombinant A cytokine mediating adaptive immune response
產品描述:IL-29與I型乾擾素和IL-10家族密切相關。 IL-29的表達由病毒感染誘導,其與由白細胞介素10受體β(IL10RB)和白細胞介素28受體α組成的異二聚體II類細胞因子受體相互作用。 IL-29與I型IFN具有共同特徵,例如抗病毒活性,抗增殖活性和體內抗腫瘤活性。 IL-29的作用類似於IFN,但一般效果較差,並且在更有限的細胞系範圍內具有活性。 響應於病毒感染產生的IL-29激活單核細胞和巨噬細胞產生限制性細胞因子組,因此它是激活病毒感染部位先天性免疫反應的重要因素。 IFN-λ1抗病毒和抗增殖活性需要干擾素-λ2受體酪氨酸殘基。

| Alternate Name | Interleukin-29, IL-29, IFN-Lambda 1, Interferon-Lambda 1, Cytokine ZCYTO21, IL29, IFNL1, ZCYTO21. |
| Gene Symbol | IFNL1 |
| Gene ID | 282618 |
| Accession # | Q8IU54 |
| Source | Human 293 cell expressed |
| Appearance | Lyophilized |
| Physical Form Description | Lyophilized in PBS. |
| Molecular Weight | 29 and 35 kDa, monomer, glycosylated |
| Purity by SDS-PAGE | > 95% |
| Endotoxin Level | < 1.0 EU per 1 μg of protein |
| Biological Activity | ED₅₀ is typically 0.5 to 5 ng/mL. The specific activity was determined by the dose-dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis |
| Reconstitution Instructions | Reconstitute in sterile PBS containing 0.1% endotoxin-free recombinant human serum albumin. |
| Handling | Centrifuge the vial prior to opening. |
| Storage Conditions | -20°C |
| Shipping Conditions | Gel Pack |
